Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $365.9700 (-6.29%) ($350.2600 - $388.0000) on Tue. Feb. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.4% (three month average) | RSI | 23 | Latest Price | $365.9700(-6.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -2.2% a day on average for past five trading days. | Weekly Trend | REGN declines -8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(64%) XLV(51%) XBI(48%) IVW(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.2% in a week (0% probabilities). VIXM(-12%) TLT(-9%) UUP(-7%) SHY(-4%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.2% (StdDev 2.4%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
Resistance Level | $435.7 | 5 Day Moving Average | $397.34(-7.9%) | 10 Day Moving Average | $407.42(-10.17%) | 20 Day Moving Average | $435.7(-16%) | To recent high | -37.7% | To recent low | 0% | Market Cap | $38.803b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |